{"created":"2023-06-19T10:43:02.620427+00:00","id":3154,"links":{},"metadata":{"_buckets":{"deposit":"30d8c43f-395b-48c0-a672-0c92f6859421"},"_deposit":{"created_by":11,"id":"3154","owners":[11],"pid":{"revision_id":0,"type":"depid","value":"3154"},"status":"published"},"_oai":{"id":"oai:shiga-med.repo.nii.ac.jp:00003154","sets":["6:7:115:116"]},"author_link":["1968","566","562","6607"],"item_3_alternative_title_18":{"attribute_name":"その他の言語のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Recent management of Cancer Chemotherapy and its Regimen Registration at Shiga University of Medical Science Hospital"}]},"item_3_alternative_title_19":{"attribute_name":"タイトル（ヨミ）","attribute_value_mlt":[{"subitem_alternative_title":"シガ イカ ダイガク イガク ブ フゾク ビョウイン シュヨウ センター ニ ヲケル ガン ヤクブツ リョウホウ ノ レジメン シンサ ト テキセイ カンリ ノ ドウコウ ニ カンスル　コウサツ"}]},"item_3_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017-03-30","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"107","bibliographicPageStart":"102","bibliographicVolumeNumber":"30","bibliographic_titles":[{"bibliographic_title":"滋賀医科大学雑誌"}]}]},"item_3_description_42":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"Departmental Bulletin Paper","subitem_description_type":"Other"}]},"item_3_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"The use of anti-cancer drugs and their combinations are becoming complex, because various new regimens for treating different types of cancer have been developed. As demonstrated by the approval of immune check point inhibitors, the regimens for cancer chemotherapy at Shiga University of Medical Science (SUMS) Hospital are becoming more diverse. In this manuscript, we evaluated the regimens approved by the chemotherapy regimen committee at SUMS Hospital before and after 2014 and discussed the roles of chemotherapy regimen registration system for the appropriate use of new anti-cancer drugs including immune check point inhibitors.","subitem_description_type":"Other"}]},"item_3_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"滋賀医科大学雑誌編集委員会"}]},"item_3_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0912-3016","subitem_source_identifier_type":"ISSN"}]},"item_3_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"高野, 淳"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"住本, 秀敏"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"寺本, 晃治"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"醍醐, 弥太郎"}],"nameIdentifiers":[{},{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-07-03"}],"displaytype":"detail","filename":"jsums3001p102.pdf","filesize":[{"value":"577.5 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"jsums3001p102","url":"https://shiga-med.repo.nii.ac.jp/record/3154/files/jsums3001p102.pdf"},"version_id":"8594a214-8517-4dfb-ace7-128690c64aa4"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"化学療法","subitem_subject_scheme":"Other"},{"subitem_subject":"レジメン","subitem_subject_scheme":"Other"},{"subitem_subject":"免疫チェックポイント阻害剤","subitem_subject_scheme":"Other"},{"subitem_subject":"Chemotherapy","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"regimen","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"滋賀医科大学医学部附属病院腫瘍センターにおけるがん薬物療法のレジメン審査と適正管理の動向に関する考察","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"滋賀医科大学医学部附属病院腫瘍センターにおけるがん薬物療法のレジメン審査と適正管理の動向に関する考察"}]},"item_type_id":"3","owner":"11","path":["116"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-07-03"},"publish_date":"2017-07-03","publish_status":"0","recid":"3154","relation_version_is_last":true,"title":["滋賀医科大学医学部附属病院腫瘍センターにおけるがん薬物療法のレジメン審査と適正管理の動向に関する考察"],"weko_creator_id":"11","weko_shared_id":-1},"updated":"2023-06-19T11:45:11.466255+00:00"}